| 17785355 |
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma
Lupi, C,
Giannini, R,
Ugolini, C,
Proietti, A,
Berti, P,
Minuto, M,
Materazzi, G,
Elisei, R,
Santoro, M,
Miccoli, P,
Basolo, F
|
J. Clin. Endocrinol. Metab. |
2007 |
| 20186005 |
Rapid multiplex real-time PCR by molecular beacons for different BRAF allele detection in papillary thyroid carcinoma
Orru, G,
Coghe, F,
Faa, G,
Pillai, S,
Manieli, C,
Montaldo, C,
Pilia, F,
Pichiri, G,
Piras, V,
Coni, P
|
Diagn. Mol. Pathol. |
2010 |
| 28344857 |
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months
Marconcini, R,
Galli, L,
Antonuzzo, A,
Bursi, S,
Roncella, C,
Fontanini, G,
Sensi, E,
Falcone, A
|
Exp Hematol Oncol |
2017 |
![BRAF K601E [cytosol] icon](/icon/R-ICO-012482.svg){kind=icon}